In a preliminary bilateral tumor model, animals sequentially injected with biomarker-specific nanoprobes demonstrated preferential accumulation of target specific probes to their respective tumors: CXCR4 targeted probes to MCF7 cells and CAV1 targeted probes to 4175TR cells. This evidence concerns the gene CXCR4 and neoplasm.